论文期刊

取消

高级检索

检索历史清除

首页> Atherosclerosis> Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis.

Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Josephine M E,Tan

第一单位： Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, the Netherlands.

作者： Josephine M E,Tan ^[1] ; Emma C L,Cook ^[1] ; Marlene,van den Berg ^[1] ; Saskia,Scheij ^[1] ; Noam,Zelcer ^[2] ; Anke,Loregger ^[3]

作者单位： Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, the Netherlands. ^[1] Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, the Netherlands. Electronic address: n.zelcer@amc.uva.nl. ^[2] Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, the Netherlands. Electronic address: a.loregger@amc.uva.nl. ^[3]

关键词 Cholesterol synthesis E2 conjugating enzymes ERAD HMGCR Post-transcriptional regulation SQLE Ubiquitylation

主题词胆固醇(Cholesterol);酶稳定性(Enzyme Stability);HEK293细胞(HEK293 Cells);Hep G2细胞(Hep G2 Cells);肝细胞(Hepatocytes);人类(Humans);羟甲基戊二酰基CoA还原酶类(Hydroxymethylglutaryl CoA Reductases);膜蛋白质类(Membrane Proteins);角鲨烯单加氧酶(Squalene Monooxygenase);时间因素(Time Factors);泛素缀合酶类(Ubiquitin-Conjugating Enzymes);泛素蛋白连接酶类(Ubiquitin-Protein Ligases);泛素化(Ubiquitination)

DOI 10.1016/j.atherosclerosis.2018.12.008

PMID 30658189

发布时间 2020-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览14

Atherosclerosis

137-142页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷